Red color represents old content. It may be empty showing addition in the new version.
Green color represents new content. It may be empty showing deletion in the new version.
Inline
Side by side
Added new contents,
deleted old contents,contents that are not changed.
New table contents
New table contents
Old table contents
Old table contents
Unchanged contents
Unchanged contents
Added new contents, contents that are not changed.
Deleted old contents, contents that are not changed.
Old table contents
Old table contents
Unchanged contents
Unchanged contents
New table contents
New table contents
Unchanged contents
Unchanged contents
Protocol summary
Transfer of frozen embryos increases cumulative pregnancy rates and decreases costs. The aim of our study is to assess the advantage of HCG injection in secretory phase plus estrogen and progesterone to transfer cryopreserved-thawed embryos. 130 women are entered to this study after inform consent. All women have failed previous in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), and they have cryopreserved embryos transfer. Women with azospermia and severe endometriosis are excluded from this study. In case group, HCG is injected 5000 IU in the first day of progesterone injection and in the embryo transfer time. Primary outcome includes chemical pregnancy that is evaluated 2 weeks after embryo transfer.
empty
Transfer of frozen embryos increases cumulative pregnancy rates and decreases costs. The aim of our study is to assess the advantage of HCG injection in secretory phase plus estrogen and progesterone to transfer cryopreserved-thawed embryos. 130 women are entered to this study after inform consent. All women have failed previous in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), and they have cryopreserved embryos transfer. Women with azospermia and severe endometriosis are excluded from this study. In case group, HCG is injected 5000 IU in the first day of progesterone injection and in the embryo transfer time. Primary outcome includes chemical pregnancy that is evaluated 2 weeks after embryo transfer.
انتقال جنینهای اضافی در سیکلهای برگشت از فریز باعث افزایش حاملگی تجمعی و کاهش هزینه میشود. هدف از این مطالعه بررسی اثر مفید اضافه کردن هورمون کوریونیک انسانی در فاز ترشحی درسیکلهایی که توسط هورمون برای انتقال جنیین برگشت از آماده شده اند میباشد. همه بیماران قبلا تحت درمان با روش لقاح داخل آزمایشگاهی یا میکروانجکشن قرار گرفته اند ، بیماران با آزواسپرمی و اندومتریوز شدید از مطالعه حذف میشوند . در گروه مداخله (HCG) هورمون کوریونیک انسانی 5000 واحد در روز تزریق HCG و روز انتقال جنین تزریق میشود.پیامد اولیه حاملگی شیمیایی است که 2 هفته بعد از انتقال جنین بررسی میشود.
empty
انتقال جنینهای اضافی در سیکلهای برگشت از فریز باعث افزایش حاملگی تجمعی و کاهش هزینه میشود. هدف از این مطالعه بررسی اثر مفید اضافه کردن هورمون کوریونیک انسانی در فاز ترشحی درسیکلهایی که توسط هورمون برای انتقال جنیین برگشت از آماده شده اند میباشد. همه بیماران قبلا تحت درمان با روش لقاح داخل آزمایشگاهی یا میکروانجکشن قرار گرفته اند ، بیماران با آزواسپرمی و اندومتریوز شدید از مطالعه حذف میشوند . در گروه مداخله (HCG) هورمون کوریونیک انسانی 5000 واحد در روز تزریق HCG و روز انتقال جنین تزریق میشود.پیامد اولیه حاملگی شیمیایی است که 2 هفته بعد از انتقال جنین بررسی میشود.
empty
The aim of our study is to assess the advantage of HCG injection in secretory phase plus estrogen and progesterone to transfer cryopreserved-thawed embryos
The aim of our study is to assess the advantage of HCG injection in secretory phase plus estrogen and progesterone to transfer cryopreserved-thawed embryos
empty
هدف از این مطالعه بررسی اثر مفید اضافه کردن هورمون کوریونیک انسانی در فاز ترشحی درسیکلهایی که توسط هورمون برای انتقال جنیین برگشت از آماده شده اند میباشد
هدف از این مطالعه بررسی اثر مفید اضافه کردن هورمون کوریونیک انسانی در فاز ترشحی درسیکلهایی که توسط هورمون برای انتقال جنیین برگشت از آماده شده اند میباشد
empty
Primary outcome chemical pregnancy that is evaluated 2 weeks after embryo transfer.
Primary outcome chemical pregnancy that is evaluated 2 weeks after embryo transfer.
empty
پیامد اولیه حاملگی شیمیایی است که 2 هفته بعد از انتقال جنین بررسی شد.
پیامد اولیه حاملگی شیمیایی است که 2 هفته بعد از انتقال جنین بررسی شد.
empty
This randomized clinical trial was conducted at the Yazd Research and Clinical Center for Infertility.This study was a randomized clinical trial. Infertile women who were candidates for frozen-thawed embryo transfers entered the study and were divided into two groups, HCG and control. The endometrial preparation method was similar in both groups.
This randomized clinical trial was conducted at the Yazd Research and Clinical Center for Infertility.This study was a randomized clinical trial. Infertile women who were candidates for frozen-thawed embryo transfers entered the study and were divided into two groups, HCG and control. The endometrial preparation method was similar in both groups.
empty
این کارآزمایی بالینی تصادفی در مرکز تحقیقات و کلینیک ناباروری یزد انجام شد. این مطالعه یک کارآزمایی بالینی تصادفی بود. زنان ناباروری که کاندیدای انتقال جنین منجمد-ذوب شده بودند ، وارد مطالعه شدند و به دو گروه HCG و شاهد تقسیم شدند. روش آماده سازی آندومتر در هر دو گروه مشابه بود.
این کارآزمایی بالینی تصادفی در مرکز تحقیقات و کلینیک ناباروری یزد انجام شد. این مطالعه یک کارآزمایی بالینی تصادفی بود. زنان ناباروری که کاندیدای انتقال جنین منجمد-ذوب شده بودند ، وارد مطالعه شدند و به دو گروه HCG و شاهد تقسیم شدند. روش آماده سازی آندومتر در هر دو گروه مشابه بود.
empty
All women have failed previous in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), and they have cryopreserved embryos transfer.Women older than 38 years, those with a body mass index (BMI) >30 kg/m2, history of endocrine disorders, and severe endometriosis were excluded from the study.
All women have failed previous in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), and they have cryopreserved embryos transfer.Women older than 38 years, those with a body mass index (BMI) >30 kg/m2, history of endocrine disorders, and severe endometriosis were excluded from the study.
empty
همه زنان در لقاح آزمایشگاهی قبلی (IVF) یا تزریق اسپرم داخل سیتوپلاسمی (ICSI) شکست خورده اند و انتقال جنین به روش انجماد دارند.زنان بالای 38 سال ، کسانی که دارای شاخص توده بدنی (BMI)> 30 کیلوگرم بر متر مربع بودند ، سابقه اختلالات غدد درون ریز و آندومتریوز شدید از مطالعه حذف شدند.
همه زنان در لقاح آزمایشگاهی قبلی (IVF) یا تزریق اسپرم داخل سیتوپلاسمی (ICSI) شکست خورده اند و انتقال جنین به روش انجماد دارند.زنان بالای 38 سال ، کسانی که دارای شاخص توده بدنی (BMI)> 30 کیلوگرم بر متر مربع بودند ، سابقه اختلالات غدد درون ریز و آندومتریوز شدید از مطالعه حذف شدند.
empty
In case group, HCG is injected 5000 IU in the first day of progesterone injection and in the embryo transfer time.
In case group, HCG is injected 5000 IU in the first day of progesterone injection and in the embryo transfer time.
empty
در گروه مداخله (HCG) هورمون کوریونیک انسانی 5000 واحد در روز تزریق HCG و روز انتقال جنین تزریق شد.
در گروه مداخله (HCG) هورمون کوریونیک انسانی 5000 واحد در روز تزریق HCG و روز انتقال جنین تزریق شد.
empty
Primary outcome includes chemical pregnancy that is evaluated 2 weeks after embryo transfer
Primary outcome includes chemical pregnancy that is evaluated 2 weeks after embryo transfer
empty
نتیجه اولیه شامل بارداری شیمیایی است که 2 هفته پس از انتقال جنین ارزیابی شد.
نتیجه اولیه شامل بارداری شیمیایی است که 2 هفته پس از انتقال جنین ارزیابی شد.
General information
40
38
4038
2011-01-01, 1389/10/11
2011-06-01, 1390/03/11
2011-0106-01 00:00:00
empty
up date clinical trial base on the latest changes in methods and enters results
up date clinical trial base on the latest changes in methods and enters results
empty
بروزرسانی کارآزمایی بالینی بر اساس آخرین تغییرات در روش کار و وارد کردن نتایج
بروزرسانی کارآزمایی بالینی بر اساس آخرین تغییرات در روش کار و وارد کردن نتایج
Inclusion criteria: History of in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) fail; cryopreservation of excess embryos
Inclusion criteria: History of in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) fail; cryopreservation of excess embryos
زنان شرکت کننده در مطالعه سابقه قبلی IVF و یا ICSI داشته و سیکل قبلی آنها با انتقال جنین تازه موفق نبوده است؛ جنین های اضافی فریز شده اند
زنان شرکت کننده در مطالعه سابقه قبلی IVF و یا ICSI داشته و سیکل قبلی آنها با انتقال جنین تازه موفق نبوده است؛ جنین های اضافی فریز شده اند
age >38 years; BMI>30; history of endocrine disorder; severe endometriosis.
age >38 years; BMI>30; history of endocrine disorder; severe endometriosis.
سن بیشتر از 30 ؛شاخص توده بدني بيشتر از 30 ؛سابقه بيماري آندوكرين؛ بيماران با اندومتریوز شدید
سن بیشتر از 30 ؛شاخص توده بدني بيشتر از 30 ؛سابقه بيماري آندوكرين؛ بيماران با اندومتریوز شدید
empty
randomization by table of random numbers
randomization by table of random numbers
empty
تصادفی سازی با استفاده از جدول اعداد تصادفی
تصادفی سازی با استفاده از جدول اعداد تصادفی
empty
empty
empty
empty
Recruitment centers
#1
Name of recruitment center - English: Yazd reserch and clinical center for infertility
Name of recruitment center - Persian: مرکزتحقیقاتی و درمانی ناباروری یزد
Full name of responsible person - English: Maryam Eftekhar
Full name of responsible person - Persian: دكتر مريم افتخار
Street address - English: Bouali Avenue, Safayeh
Street address - Persian: صفائيه، خیابان بوعلی
City - English: Yazd
City - Persian: یزد
Province:
Country: Iran (Islamic Republic of)
Postal code:
Phone:
Fax:
Email:
Web page address:
Name of recruitment center - English: Yazd reserch and clinical center for infertility
Name of recruitment center - Persian: مرکزتحقیقاتی و درمانی ناباروری یزد
Full name of responsible person - English: Maryam Eftekhar
Full name of responsible person - Persian: دكتر مريم افتخار
Street address - English: Bouali Avenue, Safayeh
Street address - Persian: صفائيه، خیابان بوعلی
City - English: Yazd
City - Persian: یزد
Province: Yazd
Country: Iran (Islamic Republic of)
Postal code: 8916877391
Phone: +98 35 3824 7085
Fax:
Email: eftekhar@ssu.ac.ir
Web page address:
Name of recruitment center - English: Yazd reserch and clinical center for infertility Name of recruitment center - Persian: مرکزتحقیقاتی و درمانی ناباروری یزد Full name of responsible person - English: Maryam Eftekhar Full name of responsible person - Persian: دكتر مريم افتخار Street address - English: Bouali Avenue, Safayeh Street address - Persian: صفائيه، خیابان بوعلی City - English: Yazd City - Persian: یزد Province: Yazd Country: Iran (Islamic Republic of) Postal code: 8916877391 Phone: +98 35 3824 7085 Fax: Email: eftekhar@ssu.ac.ir Web page address:
Sponsors / Funding sources
#1
contact.organization_id:
Name of organization / entity - English: Yazd reaserch and clinical center for infertility
Name of organization / entity - Persian: مرکز تحقیقاتی درمانی ناباروری یزد
Full name of responsible person - English: Dr.Abbas Aflatoonian
Full name of responsible person - Persian: دکتر عباس افلاطونیان
Street address - English: Bouali Avenue, Safayeh
Street address - Persian: صفاییه، خیابان بوعلی
City - English: Yazd
City - Persian: یزد
Province:
Country: Iran (Islamic Republic of)
Postal code:
Phone:
Fax:
Email:
Web page address:
contact.organization_id:
Name of organization / entity - English: Yazd reaserch and clinical center for infertility
Name of organization / entity - Persian: مرکز تحقیقاتی درمانی ناباروری یزد
Full name of responsible person - English: Dr.Abbas Aflatoonian
Full name of responsible person - Persian: دکتر عباس افلاطونیان
Street address - English: Bouali Avenue, Safayeh
Street address - Persian: صفاییه، خیابان بوعلی
City - English: Yazd
City - Persian: یزد
Province: Yazd
Country: Iran (Islamic Republic of)
Postal code: 8916877391
Phone: +98 35 3824 7085
Fax:
Email: abbas_aflatoonian@yahoo.com
Web page address:
contact.organization_id: Name of organization / entity - English: Yazd reaserch and clinical center for infertility Name of organization / entity - Persian: مرکز تحقیقاتی درمانی ناباروری یزد Full name of responsible person - English: Dr.Abbas Aflatoonian Full name of responsible person - Persian: دکتر عباس افلاطونیان Street address - English: Bouali Avenue, Safayeh Street address - Persian: صفاییه، خیابان بوعلی City - English: Yazd City - Persian: یزد Province: Yazd Country: Iran (Islamic Republic of) Postal code: 8916877391 Phone: +98 35 3824 7085 Fax: Email: abbas_aflatoonian@yahoo.com Web page address:
empty
Public
public
empty
Domestic
domestic
empty
Academic
academic
Person responsible for general inquiries
contact.organization_id:
Name of organization / entity - English: Yazd research center for infertility
Name of organization / entity - Persian: مرکز تحقیقات ناباروری یزد
Full name of responsible person - English: Dr Maryam Eftekhar
Full name of responsible person - Persian: دکتر مریم افتخار
Position - English: Assisted professor
Position - Persian: استادیار
Latest degree:
Area of specialty/work: 0
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English: Bouali Avenue, Safayeh
Street address - Persian: صفاییه، خیابان بوعلی
City - English: Yazd
City - Persian: یزد
Province:
Province - English:
Province - Persian:
contact.provinces_available: 1
Country: Iran (Islamic Republic of)
Postal code:
Phone: +98 35 1824 7085
Mobile:
Fax:
Email: eftekhar@ssu.ac.ir
Web page address:
contact.organization_id:
Name of organization / entity - English: Yazd research center for infertility
Name of organization / entity - Persian: مرکز تحقیقات ناباروری یزد
Full name of responsible person - English: Dr Maryam Eftekhar
Full name of responsible person - Persian: دکتر مریم افتخار
Position - English: Assisted professor
Position - Persian: استادیار
Latest degree: med_doctor
Area of specialty/work: 0
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English: Bouali Avenue, Safayeh
Street address - Persian: صفاییه، خیابان بوعلی
City - English: Yazd
City - Persian: یزد
Province: Yazd
Province - English:
Province - Persian:
contact.provinces_available: 1
Country: Iran (Islamic Republic of)
Postal code: 8916877391
Phone: +98 35 1824 7085
Mobile: +98 913 156 3078
Fax:
Email: eftekhar@ssu.ac.ir
Web page address:
contact.organization_id: Name of organization / entity - English: Yazd research center for infertility Name of organization / entity - Persian: مرکز تحقیقات ناباروری یزد Full name of responsible person - English: Dr Maryam Eftekhar Full name of responsible person - Persian: دکتر مریم افتخار Position - English: Assisted professor Position - Persian: استادیار Latest degree: med_doctor Area of specialty/work: 0 Area of specialty/work title - English: Area of specialty/work title - Persian: Street address - English: Bouali Avenue, Safayeh Street address - Persian: صفاییه، خیابان بوعلی City - English: Yazd City - Persian: یزد Province: Yazd Province - English: Province - Persian: contact.provinces_available: 1 Country: Iran (Islamic Republic of) Postal code: 8916877391 Phone: +98 35 1824 7085 Mobile: +98 913 156 3078 Fax: Email: eftekhar@ssu.ac.ir Web page address:
Person responsible for scientific inquiries
contact.organization_id:
Name of organization / entity - English: Yazd reserarch and clinical center for infertility
Name of organization / entity - Persian: مرکز تحقیقات ناباروری یزد
Full name of responsible person - English: Dr Maryam Eftekhar
Full name of responsible person - Persian: دکتر مریم افتخار
Position - English: Assisted professor
Position - Persian: استادیار
Latest degree:
Area of specialty/work: 0
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English: Bouali Avenue, Safayeh
Street address - Persian: صفاییه، خیابان بوعلی
City - English: Yazd
City - Persian: یزد
Province:
Province - English:
Province - Persian:
contact.provinces_available: 1
Country: Iran (Islamic Republic of)
Postal code:
Phone: +98 35 1824 7085
Mobile:
Fax:
Email: eftekhar@ssu.ac.ir
Web page address:
contact.organization_id:
Name of organization / entity - English: Yazd reserarch and clinical center for infertility
Name of organization / entity - Persian: مرکز تحقیقات ناباروری یزد
Full name of responsible person - English: Dr Maryam Eftekhar
Full name of responsible person - Persian: دکتر مریم افتخار
Position - English: Assisted professor
Position - Persian: استادیار
Latest degree: med_doctor
Area of specialty/work: 0
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English: Bouali Avenue, Safayeh
Street address - Persian: صفاییه، خیابان بوعلی
City - English: Yazd
City - Persian: یزد
Province: Yazd
Province - English:
Province - Persian:
contact.provinces_available: 1
Country: Iran (Islamic Republic of)
Postal code: 8916877391
Phone: +98 35 1824 7085
Mobile: +98 913 156 3078
Fax:
Email: eftekhar@ssu.ac.ir
Web page address:
contact.organization_id: Name of organization / entity - English: Yazd reserarch and clinical center for infertility Name of organization / entity - Persian: مرکز تحقیقات ناباروری یزد Full name of responsible person - English: Dr Maryam Eftekhar Full name of responsible person - Persian: دکتر مریم افتخار Position - English: Assisted professor Position - Persian: استادیار Latest degree: med_doctor Area of specialty/work: 0 Area of specialty/work title - English: Area of specialty/work title - Persian: Street address - English: Bouali Avenue, Safayeh Street address - Persian: صفاییه، خیابان بوعلی City - English: Yazd City - Persian: یزد Province: Yazd Province - English: Province - Persian: contact.provinces_available: 1 Country: Iran (Islamic Republic of) Postal code: 8916877391 Phone: +98 35 1824 7085 Mobile: +98 913 156 3078 Fax: Email: eftekhar@ssu.ac.ir Web page address:
Person responsible for updating data
contact.organization_id:
Name of organization / entity - English: Yazd research and clinical center for infertility
Name of organization / entity - Persian: مرکز تحقیقات ناباروری
Full name of responsible person - English: Dr Maryam Eftekhar
Full name of responsible person - Persian: دکتر مریم افتخار
Position - English: Assisted professor
Position - Persian: استادیار
Latest degree:
Area of specialty/work: 0
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English: Bouali Avenue, Safayeh
Street address - Persian: صفاییه، خیابان بوعلی
City - English: Yazd
City - Persian: یزد
Province:
Province - English:
Province - Persian:
contact.provinces_available: 1
Country: Iran (Islamic Republic of)
Postal code:
Phone: +98 35 1824 7085
Mobile: +98 913 156 3078
Fax:
Email:
Web page address:
contact.organization_id:
Name of organization / entity - English: Yazd research and clinical center for infertility
Name of organization / entity - Persian: مرکز تحقیقات ناباروری
Full name of responsible person - English: Dr Maryam Eftekhar
Full name of responsible person - Persian: دکتر مریم افتخار
Position - English: Assisted professor
Position - Persian: استادیار
Latest degree: med_doctor
Area of specialty/work: 49
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English: Bouali Avenue, Safayeh
Street address - Persian: صفاییه، خیابان بوعلی
City - English: Yazd
City - Persian: یزد
Province: Yazd
Province - English:
Province - Persian:
contact.provinces_available: 1
Country: Iran (Islamic Republic of)
Postal code: 8916877391
Phone: +98 35 1824 7085
Mobile: +98 913 156 3078
Fax:
Email: eftekhar@ssu.ac.ir
Web page address:
contact.organization_id: Name of organization / entity - English: Yazd research and clinical center for infertility Name of organization / entity - Persian: مرکز تحقیقات ناباروری Full name of responsible person - English: Dr Maryam Eftekhar Full name of responsible person - Persian: دکتر مریم افتخار Position - English: Assisted professor Position - Persian: استادیار Latest degree: med_doctor Area of specialty/work: 049 Area of specialty/work title - English: Area of specialty/work title - Persian: Street address - English: Bouali Avenue, Safayeh Street address - Persian: صفاییه، خیابان بوعلی City - English: Yazd City - Persian: یزد Province: Yazd Province - English: Province - Persian: contact.provinces_available: 1 Country: Iran (Islamic Republic of) Postal code: 8916877391 Phone: +98 35 1824 7085 Mobile: +98 913 156 3078 Fax: Email: eftekhar@ssu.ac.ir Web page address:
Sharing plan
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
empty
All participant data sets are to be shared
All participant data sets are to be shared
empty
کل داده ها بالقوه پس از غیر قابل شناسایی کردن افراد قابل اشتراک گذاری است
کل داده ها بالقوه پس از غیر قابل شناسایی کردن افراد قابل اشتراک گذاری است
empty
2 months after the result publication
2 months after the result publication
empty
2 ماه بعد از چاپ نتایج
2 ماه بعد از چاپ نتایج
empty
A journal in which the results are published
A journal in which the results are published
empty
A journal in which the results are published
A journal in which the results are published
empty
Submission of an official application via the agent that is legally in charge
Submission of an official application via the agent that is legally in charge
empty
درخواست رسمی از طریق مرجع قانونی
درخواست رسمی از طریق مرجع قانونی
empty
Yazd Reproductive Sciences Institute, Bouali Ave, Yazd, Iran.
983538247085
Yazd Reproductive Sciences Institute, Bouali Ave, Yazd, Iran. 983538247085
empty
Yazd Reproductive Sciences Institute, Bouali Ave, Yazd, Iran.
983538247085
Yazd Reproductive Sciences Institute, Bouali Ave, Yazd, Iran. 983538247085
empty
Request from the Research Deputy, submitted to the Research Council of the Center if the request accepts its referral to the security and after completion of the relevant forms, the request is referred to the research experts and then get the data.
Request from the Research Deputy, submitted to the Research Council of the Center if the request accepts its referral to the security and after completion of the relevant forms, the request is referred to the research experts and then get the data.
empty
درخواست از معاونت پژوهشی ، مطرح شدن در شورای پژوهشی مرکز ناباروری ،درصورت قبول درخواست ارجاع به حراست مرکز و تکمیل فرمهای مربوطه، ارجاع به کارشناس پژوهشی و دریافت داده ها
درخواست از معاونت پژوهشی ، مطرح شدن در شورای پژوهشی مرکز ناباروری ،درصورت قبول درخواست ارجاع به حراست مرکز و تکمیل فرمهای مربوطه، ارجاع به کارشناس پژوهشی و دریافت داده ها
Abstract
Background:
Human chorionic gonadotropin (HCG), one of the initial embryonic signals, is probably a major regulator of the embryo-endometrial relationship. This study aims to assess the advantage of HCG supplementation during the secretory phase of hormonally prepared cycles for the transfer of cryopreserved-thawed embryos.
Materials and Methods:
This study was a randomized clinical trial. Infertile women who were candidates for frozen-thawed embryo transfers entered the study and were divided into two groups, HCG and control. The endometrial preparation method was similar in both groups: all women received estradiol valerate (6 mg) po per day from the second day of the menstrual cycle and progesterone in oil (100 mg) intramuscular (I.M.) when the endometrial thickness reached 8 mm. Estradiol and progesterone were continued until the tenth week of gestation. In the HCG group, patients received an HCG 5000 IU injection on the first day of progesterone administration and the day of embryo transfer.
Results:
In this study, 130 couples participated: 65 in the HCG group and 65 in the control group. There was no statistically significant difference between groups regarding basic characteristics. Implantation rate, chemical pregnancy, clinical pregnancy, ongoing pregnancy, and abortion rates were similar in both groups.
Conclusion:
Although HCG has some advantages in assisted reproductive technology (ART) cycles, our study did not show any benefit of HCG supplementation during the secretory phase of frozen cycles (Registration Number: IRCT201107266420N4).
Keywords: ART, Implantation, Frozen Embryo, HCG
Abstract Background: Human chorionic gonadotropin (HCG), one of the initial embryonic signals, is probably a major regulator of the embryo-endometrial relationship. This study aims to assess the advantage of HCG supplementation during the secretory phase of hormonally prepared cycles for the transfer of cryopreserved-thawed embryos. Materials and Methods: This study was a randomized clinical trial. Infertile women who were candidates for frozen-thawed embryo transfers entered the study and were divided into two groups, HCG and control. The endometrial preparation method was similar in both groups: all women received estradiol valerate (6 mg) po per day from the second day of the menstrual cycle and progesterone in oil (100 mg) intramuscular (I.M.) when the endometrial thickness reached 8 mm. Estradiol and progesterone were continued until the tenth week of gestation. In the HCG group, patients received an HCG 5000 IU injection on the first day of progesterone administration and the day of embryo transfer. Results: In this study, 130 couples participated: 65 in the HCG group and 65 in the control group. There was no statistically significant difference between groups regarding basic characteristics. Implantation rate, chemical pregnancy, clinical pregnancy, ongoing pregnancy, and abortion rates were similar in both groups. Conclusion: Although HCG has some advantages in assisted reproductive technology (ART) cycles, our study did not show any benefit of HCG supplementation during the secretory phase of frozen cycles (Registration Number: IRCT201107266420N4). Keywords: ART, Implantation, Frozen Embryo, HCG
Protocol summary
Study aim
The aim of our study is to assess the advantage of HCG injection in secretory phase plus estrogen and progesterone to transfer cryopreserved-thawed embryos
Design
Primary outcome chemical pregnancy that is evaluated 2 weeks after embryo transfer.
Settings and conduct
This randomized clinical trial was conducted at the Yazd Research and Clinical Center for Infertility.This study was a randomized clinical trial. Infertile women who were candidates for frozen-thawed embryo transfers entered the study and were divided into two groups, HCG and control. The endometrial preparation method was similar in both groups.
Participants/Inclusion and exclusion criteria
All women have failed previous in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), and they have cryopreserved embryos transfer.Women older than 38 years, those with a body mass index (BMI) >30 kg/m2, history of endocrine disorders, and severe endometriosis were excluded from the study.
Intervention groups
In case group, HCG is injected 5000 IU in the first day of progesterone injection and in the embryo transfer time.
Main outcome variables
Primary outcome includes chemical pregnancy that is evaluated 2 weeks after embryo transfer
General information
Reason for update
up date clinical trial base on the latest changes in methods and enters results
Acronym
IRCT registration information
IRCT registration number:IRCT201107266420N4
Registration date:2011-09-18, 1390/06/27
Registration timing:retrospective
Last update:2021-03-08, 1399/12/18
Update count:2
Registration date
2011-09-18, 1390/06/27
Registrant information
Name
Maryam Eftekhar
Name of organization / entity
Yazd Research and Clinical Center for Infertility
Country
Iran (Islamic Republic of)
Phone
+98 35182470856
Email address
eftekhar@ssu.ac.ir
Recruitment status
Recruitment complete
Funding source
Shahid sadoughi university of medical sciences
Expected recruitment start date
2009-01-01, 1387/10/12
Expected recruitment end date
2011-06-01, 1390/03/11
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of human chorionic gonadotropin (HCG) addition during secretary phase in frozen-thawed embryo transfer cycles
Public title
Comparison of two protocols for transfer of the frozen embryos
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Inclusion criteria: History of in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) fail; cryopreservation of excess embryos
Exclusion criteria:
age >38 years; BMI>30; history of endocrine disorder; severe endometriosis.
Age
From 18 years old to 38 years old
Gender
Female
Phase
2
Groups that have been masked
No information
Sample size
Target sample size:
120
Randomization (investigator's opinion)
Randomized
Randomization description
randomization by table of random numbers
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Yazd reserch and clinical center for infertility
Street address
Booali street
City
Yazd
Province
Yazd
Postal code
8916877391
Approval date
2011-06-20, 1390/03/30
Ethics committee reference number
928
Health conditions studied
1
Description of health condition studied
infertility
ICD-10 code
N99
ICD-10 code description
Postprocedural disorders of genitourinary system, not elsewhere classified
Primary outcomes
1
Description
chemical pregnancy
Timepoint
2 weeks
Method of measurement
serum BHCG
Secondary outcomes
1
Description
clinical sonography
Timepoint
2 weeks
Method of measurement
sonography
Intervention groups
1
Description
Intervention: all women receive estradiol valerate 6 mg PO per day from the second day of menstrual cycle. Endometrial thickness is assessing by using vaginal ultrasonography since 13th day of cycle. Progesterone 100mg is injected when endomethrial thickness reaches to 8 mm. Estradiol and progesterone consumption are continued until 10th weeks of gestational age. HCG 5000 IU is injected in the first day of progesterone injection and in the day of embryo transfer.
Category
Treatment - Drugs
2
Description
Control: all women receive estradiol valerate 6 mg PO per day from the second day of menstrual cycle. Endometrial thickness is assessing by using vaginal ultrasonography since 13th day of cycle. Progesterone 100mg is injected when endomethrial thickness reaches to 8 mm. Estradiol and progesterone consumption are continued until 10th weeks of gestational age.
Category
Treatment - Drugs
Recruitment centers
1
Recruitment center
Name of recruitment center
Yazd reserch and clinical center for infertility
Full name of responsible person
Maryam Eftekhar
Street address
Bouali Avenue, Safayeh
City
Yazd
Province
Yazd
Postal code
8916877391
Phone
+98 35 3824 7085
Fax
Email
eftekhar@ssu.ac.ir
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Yazd reaserch and clinical center for infertility
Full name of responsible person
Dr.Abbas Aflatoonian
Street address
Bouali Avenue, Safayeh
City
Yazd
Province
Yazd
Postal code
8916877391
Phone
+98 35 3824 7085
Email
abbas_aflatoonian@yahoo.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Yazd reaserch and clinical center for infertility
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Yazd research center for infertility
Full name of responsible person
Dr Maryam Eftekhar
Position
Assisted professor
Latest degree
Medical doctor
Other areas of specialty/work
Street address
Bouali Avenue, Safayeh
City
Yazd
Province
Yazd
Postal code
8916877391
Phone
+98 35 1824 7085
Fax
Email
eftekhar@ssu.ac.ir
Web page address
Person responsible for scientific inquiries
Contact
Name of organization / entity
Yazd reserarch and clinical center for infertility
Full name of responsible person
Dr Maryam Eftekhar
Position
Assisted professor
Latest degree
Medical doctor
Other areas of specialty/work
Street address
Bouali Avenue, Safayeh
City
Yazd
Province
Yazd
Postal code
8916877391
Phone
+98 35 1824 7085
Fax
Email
eftekhar@ssu.ac.ir
Web page address
Person responsible for updating data
Contact
Name of organization / entity
Yazd research and clinical center for infertility
Full name of responsible person
Dr Maryam Eftekhar
Position
Assisted professor
Latest degree
Medical doctor
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Bouali Avenue, Safayeh
City
Yazd
Province
Yazd
Postal code
8916877391
Phone
+98 35 1824 7085
Fax
Email
eftekhar@ssu.ac.ir
Web page address
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
All participant data sets are to be shared
When the data will become available and for how long
2 months after the result publication
To whom data/document is available
A journal in which the results are published
Under which criteria data/document could be used
Submission of an official application via the agent that is legally in charge
From where data/document is obtainable
Yazd Reproductive Sciences Institute, Bouali Ave, Yazd, Iran.
983538247085
What processes are involved for a request to access data/document
Request from the Research Deputy, submitted to the Research Council of the Center if the request accepts its referral to the security and after completion of the relevant forms, the request is referred to the research experts and then get the data.
Comments
Trial results
Please tick if results have been published
Yes
Summary result posting date
2021-03-08, 1399/12/18
Table of baseline comparison
Basic patient characteristics in the two groups
Variables
HCG group Mean (SD)
Control group Mean (SD)
P value
Age (Years)
28.47 ± 4.14
28.84 ± 3.71
0.549
Duration of infertility (Years)
6.58 ± 2.9
6.09 ± 2.74
0.368
Basal FSH (IU/L)
5.15 ± 1.66
5.60 ± 1.72
0.135
BMI (kg/m2)
23.67 ± 2.43
23.86 ± 2.3
0.661
Etiology of infertility
Ovulatory , n (%)
13 (20)
13 (20)
0.201
Tubal, n (%)
9 (13.8)
10 (15.4)
Unexplained, n (%)
0 (0.0)
4 (3.1)
Mixed, n (%)
42 (64.6)
35 (53.8)
Male, n (%)
1 (1.5)
4 (3.1)
Total, n (%)
63 (100)
65 (100)
Participant flow diagram
Table of variable outcomes' results
ART outcome in both groups
Variables
HCG group
Control group
P Value
Implantation rate (%)
21.02
17.44
0.488
Chemical pregnancy rate, n (%)
27 (41.5)
25 (38.5)
0.429
Clinical pregnancy rate, n (%)
22 (30.8)
20 (30.8.7)
0.426
Ongoing pregnancy rate, n (%)
20 (30.8)
18 (27.7)
0.424
Miscarriage rate, n (%)
7 (25.9)
7 (28.0.4)
0.556
Endometrial thickness (mm)
8.83±1.6
9.08±1.2
0.528
Table of adverse events
First publication date
2012-12-30, 1391/10/10
Abstract of published paper
Abstract
Background:
Human chorionic gonadotropin (HCG), one of the initial embryonic signals, is probably a major regulator of the embryo-endometrial relationship. This study aims to assess the advantage of HCG supplementation during the secretory phase of hormonally prepared cycles for the transfer of cryopreserved-thawed embryos.
Materials and Methods:
This study was a randomized clinical trial. Infertile women who were candidates for frozen-thawed embryo transfers entered the study and were divided into two groups, HCG and control. The endometrial preparation method was similar in both groups: all women received estradiol valerate (6 mg) po per day from the second day of the menstrual cycle and progesterone in oil (100 mg) intramuscular (I.M.) when the endometrial thickness reached 8 mm. Estradiol and progesterone were continued until the tenth week of gestation. In the HCG group, patients received an HCG 5000 IU injection on the first day of progesterone administration and the day of embryo transfer.
Results:
In this study, 130 couples participated: 65 in the HCG group and 65 in the control group. There was no statistically significant difference between groups regarding basic characteristics. Implantation rate, chemical pregnancy, clinical pregnancy, ongoing pregnancy, and abortion rates were similar in both groups.
Conclusion:
Although HCG has some advantages in assisted reproductive technology (ART) cycles, our study did not show any benefit of HCG supplementation during the secretory phase of frozen cycles (Registration Number: IRCT201107266420N4).
Keywords: ART, Implantation, Frozen Embryo, HCG